Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose. (2nd November 2021)

• Record Type: Journal Article
• Authors: V A, Binson; Subramoniam, M.; Mathew, Luke
• Is Part Of: Expert review of molecular diagnostics. Volume 21:Number 11(2021)
• Page Start: 1223
• Page End: 1233
• Publication Date: 2021-11-02
• Subjects: COPD -- lung cancer -- breath analysis -- volatile organic compounds -- electronic nose; Molecular diagnosis -- Periodicals; 616.0758205
• DOI: 10.1080/14737159.2021.1971079
• Languages: English
• ISSNs: 1473-7159

Abstract

ABSTRACT: Introduction: This paper describes the research work done toward the development of a breath analyzing electronic nose (e-nose), and the results obtained from testing patients with lung cancer, patients with chronic obstructive pulmonary disease (COPD), and healthy controls. Pulmonary diseases like COPD and lung cancer are detected with MOS sensor array-based e-noses. The e-nose device with the sensor array, data acquisition system, and pattern recognition can detect the variations of volatile organic compounds (VOC) present in the expelled breath of patients and healthy controls. Materials and methods: This work presents the e-nose equipment design, study subjects selection, breath sampling procedures, and various data analysis tools. The developed e-nose system is tested in 40 patients with lung cancer, 48 patients with COPD, and 90 healthy controls. Results: In differentiating lung cancer and COPD from controls, support vector machine (SVM) with 3-fold cross-validation outperformed all other classifiers with an accuracy of 92.3% in cross-validation. In external validation, the same discrimination was achieved by k-nearest neighbors (k-NN) with 75.0% accuracy. Conclusion: The reported results show that the VOC analysis with an e-nose system holds exceptional possibilities in noninvasive disease diagnosis applications.